Tagged with MENA

Pharma The Managing Director of MSD Egypt highlights MSD’s unique incentives to further collaborate with the Egyptian medical community and explains how market peculiarities shape product launches in developing countries like Egypt. As newly appointed Managing Director for MSD Egypt, could you please outline your objectives and ambitions in the Egyptian…

Pharma “Egypt will become the largest market for pharmaceuticals within the region in the next three years”; Ahsraf Elkhouly, Executive Director the Egyptian Society for Pharmaceutical Research (ESPR), highlights Egypt’s untapped potential and explains the challenges currently being overcome in Egypt’s pharmaceutical sector. What makes Egypt the ‘go to’ market in…

Menarini Menarini’s Turkish subsidiary, Ibrahim Etem Menarini, has adapted to the current pharmaceutical market and is positioned to grow in several segments including their new OTC business, but is constrained by their current capacity which has minimal excess in some specific lines of production. Uğur Bingöl, the new managing director discusses…

Menarini Austria Dr. Nikitsch, you started Menarini’s Austrian operations almost 13 years ago. Would you say that Menarini’s presence in Austria today reflects the vision you had for the company in Austria at its creation? I would go beyond this statement and say that Menarini Austria is more today than we expected…

market You established Menarini’s Irish affiliate in 1999. How have you seen the market evolve over these last 13 years? The major changes in the market have principally occurred in the last four or five years, rather than the previous ten. Generally speaking, the industry has always had a very strong…

Menarini Pharma Netherlands Menarini is an extremely proud Italian company in its origins, but also very reliant on international markets. In 2009 approximately 63% of the group’s consolidated revenues came from abroad. What is the strategic role that the Netherlands and the Dutch market play for Menarini globally? When we started in 1996,…

Menarini After 67 years in the pharmaceutical industry, of which 45 at the head of Menarini, what would you say have been your personal keys to success? Most of my life, I worked three shifts. Meaning arriving at the office at 8:30am, come back home at 1pm, back to work at…

Berlin Chemie/Menarini When we met Dr. Aleiotti in Italy, he said how important was Menarini´s acquisition of Berlin Chemie in the 1990s for the internationalization of the company in Eastern Europe and Central Asia. As the CEO of Berlin Chemie for the last seven years, what would you highlight as the main…